JAMES CUNNAR: Open Payments
NPI 1164538617 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$979 in 45 payments from 19 companies in 2025. Trend: 2023 $718 · 2024 $1,117 · 2025 $979
Food & beverage: $979
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $217 |
| ABBVIE INC. | 7 | $167 |
| Lilly USA, LLC | 4 | $81 |
| Dexcom, Inc. | 2 | $60 |
| PFIZER INC. | 3 | $57 |
| Agios Pharmaceuticals, Inc. | 2 | $56 |
| Amgen Inc. | 2 | $49 |
| SANOFI PASTEUR INC. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
Products named: QULIPTA, MOUNJARO, Rybelsus, Dexcom G6 Transmitter, PYRUKYND, Wegovy, UBRELVY, Ozempic.
Industry payments across IL — which companies pay providers there.
